Beginning in January UnitedHealthcare will no longer pay physicians to remotely monitor the data that patients collect at home about chronic conditions like hypertension. The updated medical policies ...
WASHINGTON — The Trump administration’s deal to expand access to and lower the cost of weight loss drugs has left industry ...
De-extinction firm Colossal Biosciences announced Tuesday that it was acquiring animal cloning firm Viagen. The same day, ...
After initially approving Penobscot County's request for CDC aid, the agency put it on hold. Meanwhile, the virus spreads.
Morning! Lots in biotech today…. New priority review vouchers from the FDA, Mark Cuban rolls out a biosimilar deal, and a ...
The Trump administration announced a deal to expand access to popular obesity drugs made by Novo Nordisk and Eli Lilly ...
Six drugs were granted a “Commissioner’s National Priority Voucher” from the FDA, which guarantees speedier reviews of drug ...
Too many Americans fall ill from contaminated food every year — and too many families experiencing tragic, preventable loss.” ...
A biomedical researcher combining advanced mouse models with human-based and computational approaches explains why we can’t ...
At no point on Thursday did anyone from the administration mention Medicare drug price negotiations, a key part of the ...
Medicare has selected the technology vendors who'll run its prior authorization pilot in New Jersey, Ohio, Oklahoma, Texas, ...
RFK Jr. has railed against drugmakers but he struck a different tone in commenting on President Trump's deal to expand access to obesity drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback